Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine (ACh) release at presynaptic cholinergic nerve terminals is a crucial process in neurotransmission, involving the synthesis, storage, and regulated exocytosis of ACh. This process is tightly controlled by autoreceptors and is essential for muscle activation, autonomic regulation, and cognitive functions. Dysregulation of ACh release is implicated in several neurological disorders.
Modulation of acetylcholine synthesis, storage, release, or degradation; agonism or antagonism of nicotinic or muscarinic acetylcholine receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Release at Presynaptic Cholinergic Nerve Terminals.